ABSTRACT Cytospin preparations of mononuclear inflammatory cells were made from bronchoalveolar lavage fluid obtained from 15 patients with interstitial lung disease (nine patients with sarcoidosis and six patients with cryptogenic fibrosing alveolitis) and six control subjects. These preparations were examined with a panel of monoclonal antibodies that have been shown to distinguish subpopulations of macrophage like cells in normal tissues. The lysosomal acid phosphatase activity of the cells was also assessed. Phenotypically distinct subpopulations of alveolar macrophages were identified in all samples studied. The results showed that all cell populations identified in bronchoalveolar lavage fluid from the groups with interstitital lung disease could be identified in the lavage fluid from normal volunteers. Some quantitative differences in the proportions of cells identified with particular reagents emerged. In each of the groups with interstitial lung disease increased proportions of cells were identified with RFD1 (interdigitating cell marker; p < 0.01) and in the cryptogenic fibrosing alveolitis group an increased proportion of alveolar macrophages was identified with RFD7 (tissue macrophage marker; p < 0.05). The possibility that quantitative changes in alveolar macrophage subsets observed in the interstitial lung disease groups are relevant to the pathogenesis of these conditions is discussed. 
Bronchoalveolar lavage is being used increasingly to obtain samples of inflammatory cells and to evaluate the function of these populations in interstitial lung disease. Alveolar macrophages are immunocompetent cells that may be central to the pathogenesis of interstitial lung diseases such as sarcoidosis and cryptogenic fibrosing alveolitis.1-3 It is clear, however, that the term alveolar macrophage may encompass a heterogeneous group of cells. 4 Monoclonal antibodies are now available to probe the heterogeneity of the mononuclear phagocyte system3-6 and along with immunocytochemical techniques7 8 can be applied to the cells obtained by bronchoalveolar lavage to determine the subpopulations of alveolar macrophages present. A phenotypic analysis of the alveolar macrophages in bronchoalveolar lavage can then be constructed with reference to the known patterns of reactivity of these monoclonal antibodies in normal tissues.
The aims of this study were (1) to determine which cell phenotypes exist among the population of alveolar macrophages in bronchoalveolar lavage fluid; (2) to determine whether there were qualitative or quantitative differences between the cell phenotypes identified in two groups of patients with interstitial lung disease and normal subjects; and (3) to attempt to relate these phenotypic changes to the immune responses occurring in the lung interstitium in these pathological processes.
Methods

STUDY POPULATION
Twenty one subjects were studied: 15 patients with interstitial lung disease (table 1) and six control subjects.
There were five men and four women aged 29-70 years with pulmonary sarcoidosis. The diagnosis was confirmed by the presence of non-caseating granulomas on transbronchial biopsy in each case, in the presence of an appropriate clinical picture and in the absence of other known causes of pulmonary granu-429 Sarcoidosis  1  39  M  II  146  69  64  42  2  70  F  III  69  62  72  NA  3  51  M  III  44  120  121  79  4  45  F  II  77  70  57  92  5  29  M  0  79  105  106  60  6  33  M  II  111  88  94  90  7 Table 5 shows the percentages of alveolar macrophages identified in bronchoalveolar lavage fluid from normal subjects and the two groups of interstitial lung disease patients with each of the panel of monoclonal antibodies and the percentage of alveolar 
Discussion
The evidence presented here shows that discrete cell phenotypes can be distinguished among alveolar macrophages obtained by bronchoalveolar lavage by immunocytological methods and that quantitative differences in the proportions of cells with particular phenotypes emerge in the interstitial lung diseases. A wide range of monoclonal antibodies reacting with cells of the monocyte-macrophage series has become available to probe the heterogeneity of the mononuclear phagocyte system. The specificity of these reagents varies from those restricted to circulating monocytes or tissue macrophages to those that have broad reactivity with monocytes and macrophages.36 As with the lymphocyte this evident heterogeneity in the expression of membrane surface antigens perhaps reflects differences in functional capabilities within the mononuclear phagocyte system.9 Five monoclonal antibodies were used to identify subpopulations of alveolar macrophages in bronchoalveolar lavage fluid from normal subjects and two groups of patients with interstitital lung disease. The patterns of reactivity of these reagents have previously been characterised in a range of normal human tissues.5 The present findings confirm previous observations in showing that some monoclonal antibodies identify antigens shared by macrophages and interdigitating cells. 5 '4 The observation that a significant increase in the proportion of RFD7 + alveolar macrophages occurred in the patients with cryptogenic fibrosing alveolitis but not in those with sarcoidosis may reflect either local influences on alveolar macrophage maturation within the pulmonary interstitium in the two conditions or the wide range of disease activity in sarcoidosis itself. The percentage of alveolar macrophages identified by the monoclonal antibodies RFDR1 and LeuM2 was similar in the controls and the groups with interstitial lung diseae, confirming a previous observation comparing patients with sarcoidosis and normal subjects.13 Using scanning and integrating microdensitometry, however, in conjunction with a mouse antihuman HLA-DR monoclonal antibody-glucose oxidase conjugate, we have been able to show that the mean density of HLA-DR antigen expression on the alveolar macrophages obtained by bronchoalveolar lavage from patients with pulmonary sarcoidosis is greater than that in control subjects (unpublished observations).
The presence of alveolar macrophages with the phenotype RFD I+, RFD2+, ACP+ in bronchoalveolar lavage fluid in the groups with interstitial lung disease may be important since we have previously found this phenotype in lung biopsy specimens from patients with pulmonary sarcoidosis,5 and such a phenotype has not been observed in normal tissues so far examined. Peripheral blood monocytes (RFDl -, RFD2+, ACP+) have been observed to develop the RFDI+, RFD2+, ACP+ phenotype in conjunction with the physical changes of maturation when grown in tissue culture (unpublished observation). Could the presence of such a phenotype in lavage fluid represent a newly arrived population of monocytes maturing into alveolar macrophages in the lung? Such an observation would be in accordance with the data of Hance et al.3 These workers used monoclonal antibodies to identify monocyte lineage surface antigens and they were able to show that in bronchoalveolar lavage fluid from patients with sarcoidosis there was an increase in the proportion of alveolar macrophages identified with monoclonal antibodies that identify antigens preferentially expressed on peripheral blood monocytes-a finding that favours the concept of increased recruitment of immature macrophages to the site of disease activity.
We believe that the use of a panel of monoclonal antibodies that allow the immunocytological dissection of discrete subsets of alveolar macrophages will ultimately lead to the evaluation of the role of such subsets in the pathogenesis of the interstitial lung diseases. Functional studies of subpopulations of alveolar macrophages defined by monoclonal antibodies are currently being undertaken in this department.
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